These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3267175)

  • 1. Exploiting the immune system's own strategies for immunotherapy.
    Lanzavecchia A
    Immunol Today; 1988 Jun; 9(6):167-8. PubMed ID: 3267175
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor immunotherapy: the tumor cell as an antigen-presenting cell.
    Ostrand-Rosenberg S
    Curr Opin Immunol; 1994 Oct; 6(5):722-7. PubMed ID: 7826527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-presenting cells for unprimed T cells.
    Sprent J; Schaefer M
    Immunol Today; 1989 Jan; 10(1):17-23. PubMed ID: 2526637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular engineering of the antitumor immune response.
    Pardoll DM; Golumbek P; Levitsky H; Jaffee L
    Bone Marrow Transplant; 1992; 9 Suppl 1():182-6. PubMed ID: 1387016
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigen presentation: structural themes and functional variations.
    Braciale TJ; Braciale VL
    Immunol Today; 1991 Apr; 12(4):124-9. PubMed ID: 1711855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
    Sensi M; Anichini A
    Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance.
    Cohen PA; Peng L; Kjaergaard J; Plautz GE; Finke JH; Koski GK; Czerniecki BJ; Shu S
    Crit Rev Immunol; 2001; 21(1-3):215-48. PubMed ID: 11642606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of antigen-presenting cells in regulating the immune response to tumor antigens.
    Drebin JA; Schatten S; Greene MI
    Transplant Proc; 1984 Oct; 16(5):1377-9. PubMed ID: 6237476
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer immunotherapy by local transfer of autologous T lymphocytes cultured with T cell growth factor and autologous tumor extract: a clinical trial.
    Kan N; Ohgaki K; Yamasaki N; Hori T; Nakayama N; Nio Y; Inamoto T; Hikasa Y
    Nihon Geka Hokan; 1983 Nov; 52(6):841-53. PubMed ID: 6380446
    [No Abstract]   [Full Text] [Related]  

  • 10. Bispecific antibodies in cancer therapy.
    Weiner LM
    Cancer J; 2000 May; 6 Suppl 3():S265-71. PubMed ID: 10874497
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
    Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
    Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro immunogenicity of antigen-presenting cell-free endocrine cells: the role of antigen presenting cells.
    Shachner MS; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1991 Feb; 23(1 Pt 1):89-90. PubMed ID: 1990716
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumour immunotherapy: the adjuvant treatment of the 21st century?
    Bremers AJ; Kuppen PJ; Parmiani G
    Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of B7-1-expressing host antigen-presenting cells for the eradication of B7-2 transfected P815 tumor cells.
    La Motte RN; Sharpe AH; Bluestone JA; Mokyr MB
    J Immunol; 1998 Dec; 161(12):6552-8. PubMed ID: 9862681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune escape of gliomas.
    Walker PR; Dietrich PY
    Prog Brain Res; 2001; 132():685-98. PubMed ID: 11545028
    [No Abstract]   [Full Text] [Related]  

  • 17. Artificial antigen-presenting cells: artificial solutions for real diseases.
    Oelke M; Krueger C; Giuntoli RL; Schneck JP
    Trends Mol Med; 2005 Sep; 11(9):412-20. PubMed ID: 16103011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous expression of Ia and cytocidal activity by macrophages, and the consequences for antigen presentation.
    Friedman A; Beller DI
    Immunology; 1987 Aug; 61(4):435-41. PubMed ID: 3127323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells for specific cancer immunotherapy.
    Meidenbauer N; Andreesen R; Mackensen A
    Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dendritic cells--and their possible applications in cancer therapy].
    Agger R; Hokland ME
    Ugeskr Laeger; 2000 Aug; 162(33):4377-81. PubMed ID: 10962960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.